Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Microparticles as a Biomarker in Distinguishing Between Thrombotic Thrombocytopenic Purpura (TTP) and Atypical Hemolytic Uremic Syndrome (aHUS)

NCT02626663 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT02626663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02626663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Microparticles as a Biomarker in Distinguishing Between Thrombotic Thrombocytopenic Purpura (TTP) and Atypical Hemolytic Uremic Syndrome (aHUS)
Lead sponsor
University of Rochester
Phase
Observational
Overall status
Withdrawn
Start date
July 31, 2016
Completion date
December 31, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atypical hemolytic uremic syndrome, microangiopathic hemolytic anemia, microparticles, thrombotic thrombocytopenic purpura